Common-Size Income Statement
Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Enterprise Value to FCFF (EV/FCFF)
- Present Value of Free Cash Flow to Equity (FCFE)
- Price to Operating Profit (P/OP) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Medtronic PLC, common-size consolidated income statement
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
| Income statement item | Description | The company |
|---|---|---|
| Operating profit | The net result for the period of deducting operating expenses from operating revenues. | Medtronic PLC operating profit as a percentage of net sales decreased from 2022 to 2023 and from 2023 to 2024. |
| Income before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Medtronic PLC income before income taxes as a percentage of net sales decreased from 2022 to 2023 and from 2023 to 2024. |
| Net income attributable to Medtronic | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Medtronic PLC net income attributable to Medtronic as a percentage of net sales decreased from 2022 to 2023 and from 2023 to 2024. |